
The Thermocool Smarttouch SF Catheter received approval for use with the CARTO® 3 System, according to a statement from the Johnson & Johnson Medical Companies.
Patrick Campbell is the editorial director of HCPLive. Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter and/or multimedia specialist with the Pocono Record, Star News Group, and NJ Advance Media. He is the executive producer for multiple HCPLive podcasts, including Diabetes Dialogue, Don't Miss a Beat, Kidney Compass, Medical Ethics Unpacked, The Medical Sisterhood, and Skin of Color Savvy.
Follow him on Twitter @RealPatCampbell or reach him via email at [email protected].

The Thermocool Smarttouch SF Catheter received approval for use with the CARTO® 3 System, according to a statement from the Johnson & Johnson Medical Companies.

A cardiologist from Brigham and Women's Hospital discusses prescribing SGLT2 inhibitors to patients with an EGFR approaching or below 30.

Muthiah Vaduganathan, MD, MPH, of Brigham and Women's discusses the barriers to preventing optimal prescribing practices for SGLT2 inhibitor and GLP-1 receptor agonist therapies.

A trial of patients with prediabetes and OSA details the cardiovascular benefit of optimized CPAP treatment.

An analysis of the REGARDS study suggests patients with greater perceived stress levels were at an increased risk of incident HFpEF.

Women with breast cancer who have the most arterial calcium accumulation are nearly 4 times more likely to develop cardiovascular disease.

An RCT of patients with prediabetes and OSA details the cardiovascular benefit of optimized CPAP treatment in this patient population.

An analysis of nationally representative data suggests 35.6% of diabetic patients reported not receiving a yearly influenza vaccination.

An analysis of data from a major women’s health study is detailing associations between adverse pregnancy outcomes and risk of atherosclerotic cardiovascular disease in postmenopausal women.

A NAMS 2020 study suggests number of menopause symptoms could help predict increased risk of cardiovascular disease in older women.

Results of a study of more than 330 patients suggest use of sitagliptin could improve outcomes in patients with diabetes and COVID-19.

Study suggests generic levothyroxine achieved similar rates of patients with thyrotropin levels in the ideal range as brand name levothyroxine.

An analysis of nearly 300k offspring suggests those exposed to diabetes in the womb were at an increased risk of cardiovascular disease events and risk factors in young adulthood.

A prespecified analysis of a clinical trial in high-risk aortic stenosis patients found no differences in health status at 5 years among patients undergoing SAVR vs TAVR.

An analysis of data from 5 major databases suggests NRTIs could reduce incidence of type 2 diabetes.

An analysis of data from the Women's Health Initiative is offering clinicians a look into the impact of menopause symptoms on cardiovascular health in older women.

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.

Kazem Rahimi, MD, discusses the prospect of home monitoring for heart failure patients and how technology needs to improve before it is a viable option for most patients.

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

Could an alarm clock in the room where stroke care is performed contribute to more streamlined care?

While rates of recurrent events have declined, the rates of decline have not been equal between sexes and risk of recurrent events still pose a serious risk to heart attack survivors.

Analysis of information from more than 1000 patients in Australia sheds light on the potential association between metformin use and slower cognitive decline in older individuals.

New data suggest resuming or increasing sexual activity shortly after myocardial infarction could reduce risk of mortality.

Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.

Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.

A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.

A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.

Results of the study offer clinicians greater insight and could improve decision-making in regards to treatment choices for hypothyroidism.

Chief member of Practical Cardiology's editorial advisory board discusses his approach to cholesterol education and the current state of cholesterol management in 2020.

Results of the analysis offer further clarity on the detrimental impact of smoking on overall and cerebrovascular health.